弥漫性大B细胞淋巴瘤基线代谢总肿瘤负荷的自动分割:哪种方法最成功?代表PETRA联盟的研究
本研究从英国和荷兰的弥漫性大B细胞淋巴瘤研究中选取140例基线18F-FDG PET/CT扫描,评估6种自动分割代谢肿瘤体积(MTV)方法的成功率。SUV4.0表现最佳,在105例(76%)扫描中给出良好的MTV近似值,另20%病例经简单编辑可获得满意结果;结论推荐SUV4.0和MV2进一步评估,自动估计MTV是可行的。
要点
- SUV4.0分割成功率最高,失败率最低,除MV2外优于其他方法。
- SUV4.0在105例(76%)扫描中给出良好MTV近似值,另20%需简单编辑。
- 所有方法在有和无进展患者间MTV均有显著差异。
核心结论
- SUV4.0和MV2被推荐用于进一步评估,自动估计MTV是可行的。
研究设计与样本
- 从英国和荷兰的弥漫性大B细胞淋巴瘤研究中选取140例基线18F-FDG PET/CT扫描,平衡60与90分钟摄取时间、扫描参数依从与非依从标准化建议、有与无进展患者。
- 应用自动工具进行分割,方法包括SUV2.5、SUV4.0、自适应阈值(A50P)、SUVmax的41%(41%)、多数投票包含至少2种方法检测的体素(MV2)和多数投票包含至少3种方法检测的体素(MV3)。
- 两名独立观察者评估工具勾画MTV的成功率;需 minimal 交互的扫描评为成功,遗漏超过50%肿瘤或需超过2步编辑的扫描评为失败。
主要发现
- 138例扫描可评估,各方法成功与失败评级存在显著差异。
- SUV4.0表现最佳,成功率高且失败率低,除MV2外优于任何其他方法;MV2也表现良好。
- SUV4.0在105例(76%)扫描中给出良好的MTV近似值,另20%病例经简单编辑获得满意结果。
- 所有方法在有和无进展患者间MTV均有显著差异。
- 41%分割方法在较长摄取时间下表现稍差;否则扫描条件和患者结局不影响工具性能。
关键数值与推荐
- 评估扫描共140例,其中138例可评估。
- SUV4.0在105例(76%)扫描中给出良好MTV近似值,另20%病例经简单编辑获得满意结果。
- 成功定义为需 minimal 交互的扫描;失败定义为遗漏超过50%肿瘤或需超过2步编辑。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Metabolic tumor volume (MTV) is a promising biomarker of pretreatment risk in diffuse large B-cell lymphoma (DLBCL). Different segmentation methods can be used that predict prognosis equally well but give different optimal cutoffs for risk stratification. Segmentation can be cumbersome; a fast, easy, and robust method is needed. Our aims were to evaluate the best automated MTV workflow in DLBCL; determine whether uptake time, compliance or noncompliance with standardized recommendations for 18F-FDG scanning, and subsequent disease progression influence the success of segmentation; and assess differences in MTVs and discriminatory power of segmentation methods. Methods: One hundred forty baseline 18F-FDG PET/CT scans were selected from U.K. and Dutch studies on DLBCL to provide a balance between scans at 60 and 90 min of uptake, parameters compliant and noncompliant with standardized recommendations for scanning, and patients with and without progression. An automated tool was applied for segmentation using an SUV of 2.5 (SUV2.5), an SUV of 4.0 (SUV4.0), adaptive thresholding (A50P), 41% of SUVmax (41%), a majority vote including voxels detected by at least 2 methods (MV2), and a majority vote including voxels detected by at least 3 methods (MV3). Two independent observers rated the success of the tool to delineate MTV. Scans that required minimal interaction were rated as a success; scans that missed more than 50% of the tumor or required more than 2 editing steps were rated as a failure. Results: One hundred thirty-eight scans were evaluable, with significant differences in success and failure ratings among methods. The best performing was SUV4.0, with higher success and lower failure rates than any other method except MV2, which also performed well. SUV4.0 gave a good approximation of MTV in 105 (76%) scans, with simple editing for a satisfactory result in additionally 20% of cases. MTV was significantly different for all methods between patients with and without progression. The 41% segmentation method performed slightly worse, with longer uptake times; otherwise, scanning conditions and patient outcome did not influence the tool's performance. The discriminative power was similar among methods, but MTVs were significantly greater using SUV4.0 and MV2 than using other thresholds, except for SUV2.5. Conclusion: SUV4.0 and MV2 are recommended for further evaluation. Automated estimation of MTV is feasible.
引用
- Barrington SF, Zwezerijnen BGJC, de Vet HCW, et al. Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium. J Nucl Med. 2020. PMID: 32680929. doi:10.2967/jnumed.119.238923
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。